|Mr. Mark H. Cheung||CEO, Pres & Director||N/A||N/A||N/A|
|Dr. Donald L. Jolly||CFO & Treasurer||N/A||N/A||N/A|
|Mr. Corey Washington||Chief Technology Officer||N/A||N/A||N/A|
|Mr. Stephen R. Pidliskey Jr.||VP & Sec.||N/A||N/A||N/A|
|Dr. Charles B. Hensley Ph.D.||Pres of Itonis Pharmaceuticals||N/A||N/A||N/A|
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Itonis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.